CBS 2019
CBSMD教育中心
English

光学相关断层扫描

科研文章

荐读文献

Clinical Predictors for Lack of Favorable Vascular Response to Statin Therapy in Patients With Coronary Artery Disease: A Serial Optical Coherence Tomography Study Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography Assessment of the coronary calcification by optical coherence tomography Volumetric characterization of human coronary calcification by frequency-domain optical coherence tomography Covering our tracks – optical coherence tomography to assess vascular healing Intravascular optical coherence tomography Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation Uncovered Culprit Plaque Ruptures in Patients With ST-Segment Elevation Myocardial Infarction Assessed by Optical Coherence Tomography and Intravascular Ultrasound With iMap Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes
|<< 1 2 3 4 5 6 7 >>|

Original Research2016 Apr;9(4):e003414.

JOURNAL：Circ Cardiovasc Interv. Article Link

Optical Coherence Tomography-Guided Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Prospective Propensity-Matched Cohort of the Thrombectomy Versus Percutaneous Coronary Intervention Alone Trial

Sheth TN, Kajander OA, Lavi S et al. Keywords: myocardial infarction; optical coherence tomography; percutaneous coronary intervention; thrombectomy

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top